Medite Cancer Diagnostics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDIT research report →
About the company
Medite Cancer Diagnostics, Inc. operates as a medical technology company. It develops, manufactures, and markets molecular biomarkers, medical devices, and consumables for the detection, risk assessment, and diagnosis of cancerous and precancerous conditions and related diseases.
- CEO
- Rahsan-Rahsan Lindsay
- IPO
- 1995
- Employees
- 69
- HQ
- Orlando, FL, US
Price Chart
- Market Cap
- $8.67K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.79
- Div Yield
- 0.00%
- Gross Margin
- -1.92%
- Op Margin
- -95.11%
- Net Margin
- -99.97%
- ROE
- -98.90%
- ROIC
- -48.19%
- Revenue
- $6.81M · -26.25%
- Net Income
- $-6,811,000 · -214.89%
- EPS
- $-0.26 · -160.00%
- Op Income
- $-6,480,000
- FCF YoY
- -125.46%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 561.38
- Avg Volume
- 175.964
Get TickerSpark's AI analysis on MDIT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 15, 18 | Lewis William Austin IV | buy | 8,973,333 |
| Oct 15, 18 | Lewis William Austin IV | buy | 80,000 |
| Jul 25, 18 | Lewis William Austin IV | buy | 1,100,000 |
| Jul 27, 18 | Von Rump Stephen L. | buy | 133,333 |
| May 2, 18 | Von Rump Stephen L. | other | 0 |
| Jul 9, 18 | Lewis William Austin IV | buy | 400,000 |
| Jul 9, 18 | Lewis William Austin IV | buy | 6,933,333 |
| Jun 28, 18 | Lewis William Austin IV | buy | 1,333,334 |
| Apr 26, 18 | Lewis William Austin IV | buy | 8,000,000 |
| Apr 4, 18 | FORTUNOFF GREGORY | buy | 1,333,334 |
Our MDIT coverage
Recent articles, reports, and earnings notes.
No research on MDIT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MDIT report →Similar companies
Peers in the same neighborhood.